exposure to microplastic: Microplastic content in cancerous and paracancerous tissues
Study summary
The objective of this study is to identify and characterize microplastics present in peritumoral and intratumoral tissues of colorectal cancer patients, and to investigate their associations with gut microbiome composition and metabolic profiles. By integrating microplastic analysis with metagenomic and metabolomic data, we aim to explore the potential impact of environmental microplastic exposure on tumor microenvironment alterations, microbial dysbiosis, and metabolic reprogramming in colorectal cancer.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adult patients (≥18 years old) with histologically confirmed colorectal adenocarcinoma.
* Undergoing elective radical colorectal cancer resection at the study hospital.
* No prior chemotherapy, radiotherapy, or targeted therapy before surgery.
* Availability of both tumor tissue and adjacent normal (peritumoral) tissue samples during surgery.
* Willingness to provide stool and/or blood samples for metagenomic and metabolomic analysis.
* Ability to understand the study procedures and provide written informed consent.
Exclusion Criteria:
* Patients with a history of other malignancies within the past 5 years.
* Emergency surgery due to obstruction, perforation, or bleeding.
* Inadequate sample quality or volume for microplastic, metagenomic, or metabolomic analysis.
* Presence of chronic inflammatory bowel disease (e.g., Crohn's disease or ulcerative colitis).
* Use of antibiotics, probiotics, or prebiotics within 4 weeks prior to sample collection.
* Pregnant or breastfeeding women.
* Refusal or inability to provide informed consent.
Primary outcome measure(s)
genomics — Blood specimens were obtained within one week prior to surgery. Genomics was tested by preoperative blood specimens.
Trial sites (1)
Facility
City
Region
Status
The First Affiliated Hospital of Chongqing Medical University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.